These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23486323)

  • 21. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
    Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
    Jeong YJ; Lee KS; Kim J; Shim YM; Han J; Kwon OJ
    AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of
    Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
    Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M; Ayabe T; Tsuchiya K; Nakamura K
    Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y
    Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
    Matsumoto I; Oda M; Takizawa M; Waseda R; Nakajima K; Kawano M; Mochizuki T; Ikeda H; Watanabe G
    Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
    Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
    Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
    Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.
    Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R
    Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.
    Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H
    Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas.
    Sadohara J; Fujimoto K; Müller NL; Kato S; Takamori S; Ohkuma K; Terasaki H; Hayabuchi N
    Eur J Radiol; 2006 Oct; 60(1):70-9. PubMed ID: 16766154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
    Lococo F; Perotti G; Cardillo G; De Waure C; Filice A; Graziano P; Rossi G; Sgarbi G; Stefanelli A; Giordano A; Granone P; Rindi G; Versari A; Rufini V
    Clin Nucl Med; 2015 Mar; 40(3):e183-9. PubMed ID: 25608152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
    Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
    Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.
    Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
    Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
    J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
    Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
    Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.